Medicinova (MNOV) Research & Development (2010 - 2026)
Medicinova (MNOV) reported Research & Development of $1.03 million for Q2 2026, down 53.0% from $2.19 million a year earlier.
Powered by 
Analysis
Medicinova (MNOV) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Medicinova's Research & Development came in at $6.34 million, down 18.6% year-over-year; for FY2025, it came in at $7.15 million, down 0.6% from FY2024.
- Research & Development has a five-year compound annual growth rate of -0.9% (FY2020 to FY2025).
- By year, Research & Development came in at $7.19 million in FY2024 (+27.2%), $5.66 million in FY2023 (-38.1%), $9.14 million in FY2022 (+7.1%) and $8.54 million in FY2021 (+14.1%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q3 2023.
- Year over year, Research & Development gained in four of the last seven quarters, with growth averaging 14.1%.
- The high point for year-over-year Research & Development in five years was Q3 2024 (growth of 134.0%); the low point was Q3 2023 (a decline of 67.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Medicinova | 103.36 Mn | 103.36 Mn | - | 1.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 794,706.00 |
| Jun 30, 2023 | 1.74 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 2.01 Mn |
| Sep 30, 2022 | 2.45 Mn |
| Jun 30, 2022 | 2.56 Mn |
| Mar 31, 2022 | 2.11 Mn |
| Dec 31, 2021 | 1.78 Mn |
| Sep 30, 2021 | 2.09 Mn |
| Jun 30, 2021 | 2.53 Mn |
API Access
Medicinova Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MNOV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MNOV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MNOV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();